BiotechTube
Home/Stelexis Therapeutics/Manuel Aivado, M.D., Ph.D.
MA

Manuel Aivado, M.D., Ph.D.

President and Chief Executive Officer

Stelexis Therapeutics

Therapeutic Areas

Hematological CancersInflammatory & Immunological Diseases

Stelexis Therapeutics Pipeline

DrugIndicationPhase
EganelisibHigher Risk-MDS and AMLPhase 1
STLX-2012Lower Risk-MDS and CMMLPre-IND to Early Clinical

Leadership Team at Stelexis Therapeutics

RA
Rossitza Alargova, Ph.D.
Head of CMC
EF
Eric Feldman, M.D.
Chief Medical Officer
View full Stelexis Therapeutics profile